...
首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family
【24h】

Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family

机译:在意大利家庭BRCA1和BRCA2基因中的双重杂合性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Double heterozygosity (DH) is an extremely rare event in which both BRCA1 and BRCA2 are mutated simultaneously in a family. To date, few cases of DH have been reported, especially in Ashkenazi populations. In Italy some cases of DH have been reported. In this study, we have described an Italian family with double heterozygosity in the BRCA genes. Methods: The proband is a 43-year-old woman with bilateral breast cancer. She presented two pathogenic mutations in both BRCA genes, IVS8+2T>A (c.547+2T>A;p.Gln148Aspfsx51) in BRCA1, K944X (c.2830A>T;p.Lys944X) in BRCA2 and a novel variant IVS4-57A>G (c.426-57A>G) in BRCA2, not previously described. Both mutations were inherited from the paternal lineage in the proband's family. We investigated all available members of this family and we identified other two family members with DH. Results and conclusions: Our observations support the hypothesis of a non-specific severe phenotype in DH carriers in terms of age of disease onset, cumulative lifetime risk and multiple primary tumours. Furthermore, our findings confirm that in order to identify all cases of DH, it is important not to limit the identification of mutations in a single gene, but extend the analysis to BRCA1 and BRCA2 and other breast cancer susceptibility genes.
机译:背景:双重杂合性(DH)是一种极其罕见的事件,其中BRCA1和BRCA2在家庭中同时突变。迄今为止,据报道,少数DH案例,特别是在Ashkenazi人口中。在意大利,已经报告了一些DH的病例。在这项研究中,我们描述了在BRCA基因中具有双重杂合子的意大利家族。方法:概念是一名43岁女性,具有双侧乳腺癌。在BRCA2和BRCA2的BRCA1,K944x(C.2830A> T; P.Lys944x)中,在BRCA基因,IVS8 + 2T> A(C.547 + 2T> A; P.Lys944x)中的两种致病性突变。在BRCA2和新型变体IVS4中-57A> G(C.426-57A> G)在BRCA2中,先前未描述。两种突变都是从父亲家族中的父系血统。我们调查了这个家庭的所有可用成员,我们确定了其他两个家庭成员,DH。结果与结论:我们的观察结果在疾病发病的年龄,累积寿命风险和多发性肿瘤方面支持DH载体中非特异性严重表型的假设。此外,我们的研究结果证实,为了识别所有DH病例,重要的是不要限制单个基因中突变的鉴定,而是将分析延伸到BRCA1和BRCA2和其他乳腺癌易感基因。

著录项

  • 来源
  • 作者单位

    Department of Biochemistry Biophysics and General Pathology Second Medical School of Naples Via;

    Department of Biochemistry Biophysics and General Pathology Second Medical School of Naples Via;

    Department of Biochemistry Biophysics and General Pathology Second Medical School of Naples Via;

    Department of Biochemistry Biophysics and General Pathology Second Medical School of Naples Via;

    Department of Biochemistry Biophysics and General Pathology Second Medical School of Naples Via;

    Department of Biochemistry Biophysics and General Pathology Second Medical School of Naples Via;

    Department of Internal Medicine Surgical Neurological Metabolic Diseases and Geriatric Medicine;

    Department of Biochemistry Biophysics and General Pathology Second Medical School of Naples Via;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 诊断学;
  • 关键词

    BRCA1/2 mutations; Breast and ovarian cancer; Double heterozygosity (DH);

    机译:BRCA1 / 2突变;乳腺癌和卵巢癌;双杂合子(DH);

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号